| Name | 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-nitropyridin-2-one |
|---|---|
| Synonyms |
5-Nitro-1-(2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)-2(1H)-pyridinone
1-(2,3,5-Tribenzoyl-O-D-ribofuranosyl)-5-nitropyridine-2(1H)-one 1-(2,3,5-Tribenzoyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one 1-(2,3,5-Tribenzoyl-D-ribofuranosyl)-5-nitropyridine-2(1H)-one 5-nitro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2-pyridone 2(1H)-Pyridinone, 5-nitro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl) 1-(2,3,5-Tri-O-benzoyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-nitropyridine-2(1H)-one |
| Description | 5-Nitro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2(1H)-pyridinone is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C31H24N2O10 |
|---|---|
| Molecular Weight | 584.53 |
| Exact Mass | 584.14300 |
| PSA | 155.95000 |
| LogP | 4.48530 |